Jack shares with the NP that lizzie's cognitive abilities continue to worsen even with the changes in medication dosage. After completing a full neurological assessment on Lizzie, the NP changes her medication from donepezil 10 mg to the combination cholinesterase inhibitor and NDMA receptor antagonist memantine/doneprizil 14mg/10mg. What is the focus of drug therapy for individuals who have AD/